Log In
BCIQ
Print this Print this
 

TW001

  Manage Alerts
Collapse Summary General Information
Company Treeway B.V.
DescriptionOral formulation of edaravone, a free radical scavenger cerebral neuroprotectant
Molecular Target Free radical
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation U.S. - Orphan Drug (Treat amyotrophic lateral sclerosis (ALS));
EU - Orphan Drug (Treat amyotrophic lateral sclerosis (ALS))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today